CA2307716A1 - Reagents and methods useful for detecting diseases of the breast - Google Patents

Reagents and methods useful for detecting diseases of the breast Download PDF

Info

Publication number
CA2307716A1
CA2307716A1 CA002307716A CA2307716A CA2307716A1 CA 2307716 A1 CA2307716 A1 CA 2307716A1 CA 002307716 A CA002307716 A CA 002307716A CA 2307716 A CA2307716 A CA 2307716A CA 2307716 A1 CA2307716 A1 CA 2307716A1
Authority
CA
Canada
Prior art keywords
sequence
polynucleotide
specific
group
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002307716A
Other languages
English (en)
French (fr)
Inventor
Patricia A. Billing-Medel
Maurice Cohen
Tracey L. Colpitts
Paula N. Friedman
Julian Gordon
Edward N. Granados
Steven C. Hodges
Michael R. Klass
Jon D. Kratochvil
John C. Russell
Stephen D. Stroupe
Hong Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2307716A1 publication Critical patent/CA2307716A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002307716A 1997-10-28 1998-10-28 Reagents and methods useful for detecting diseases of the breast Abandoned CA2307716A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96883897A 1997-10-28 1997-10-28
US6343197P 1997-10-28 1997-10-28
US08/968,838 1997-10-28
US60/063,431 1997-10-28
PCT/US1998/022906 WO1999022027A1 (en) 1997-10-28 1998-10-28 Reagents and methods useful for detecting diseases of the breast

Publications (1)

Publication Number Publication Date
CA2307716A1 true CA2307716A1 (en) 1999-05-06

Family

ID=26743420

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002307716A Abandoned CA2307716A1 (en) 1997-10-28 1998-10-28 Reagents and methods useful for detecting diseases of the breast

Country Status (3)

Country Link
EP (1) EP1027457A1 (de)
CA (1) CA2307716A1 (de)
WO (1) WO1999022027A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3354199A (en) * 1998-03-12 1999-09-27 Millennium Biotherapeutics, Inc. Prostate derived serine protease (pdsp) protein and nucleic acid molecules and uses therefor
AU2002230736A1 (en) * 2000-10-30 2002-05-15 Diadexus, Inc. Compositions and methods relating to breast specific genes and proteins
EP1349934A2 (de) * 2000-11-20 2003-10-08 Diadexus, Inc. Zusammensetzungen und verfahren in verbindung mit brustspezifischen genen und proteinen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5962300A (en) * 1997-03-26 1999-10-05 Incyte Pharmaceuticals, Inc. Human kallikrein

Also Published As

Publication number Publication date
WO1999022027A1 (en) 1999-05-06
EP1027457A1 (de) 2000-08-16

Similar Documents

Publication Publication Date Title
CA2269634A1 (en) Reagents and methods useful for detecting diseases of the breast
EP0108564B1 (de) Methoden zur Feststellung von Oncogenese
US6887660B2 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
EP1876241A2 (de) Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Brustkrebs
KR101446626B1 (ko) 신장암 진단, 신장암 환자 예후 예측을 위한 조성물 및 방법
EP2143731A1 (de) Verbindungen für Prostatakrebs- Immuntherapie und Methode für ihre Verwendung
CA2362830A1 (en) Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
JP2002507387A (ja) 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
CA2362527A1 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
EP1964850A2 (de) Zusammensetzungen und Methoden zur Behandlung und Diagnose von Brustkrebs
CA2287571A1 (en) Reagents and methods useful for detecting diseases of the prostate
CA2329137A1 (en) Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer
CA2232237A1 (en) Reagents and methods useful for detecting diseases of the breast
JP2001521744A5 (de)
WO1997025431A1 (en) Compositions and methods for the treatment and diagnosis of cancer
EP1131095A1 (de) Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs
EP1107798A1 (de) Neues verfahren zur diagnose, überwachung, klassifizierung, bildgebung und behandlung von kolonkrebs
JP2003512036A5 (de)
US6387697B1 (en) Compositions for treatment and diagnosis of breast cancer and methods for their use
CA2307716A1 (en) Reagents and methods useful for detecting diseases of the breast
JP2003523171A5 (de)
US6379951B1 (en) Compounds for immunotherapy of breast cancer and methods for their use
WO2000020640A1 (en) A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US5231009A (en) Cdnas coding for members of the carcinoembryonic antigen family
JP2003532369A5 (de)

Legal Events

Date Code Title Description
FZDE Discontinued